An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

Conditions

• Corona Virus Infection
• Vaccine
• COVID-19

Interventions

• BIOLOGICAL: CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"

Sponsor

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products